Construction of a metabolism-malnutrition-inflammation prognostic risk score in patients with heart failure with preserved ejection fraction: a machine learning based Lasso-Cox model

被引:1
作者
Feng, Jiayu [1 ]
Huang, Liyan [1 ]
Zhao, Xuemei [1 ]
Li, Xinqing [1 ]
Xin, Anran [1 ]
Wang, Chengyi [1 ]
Zhang, Yuhui [1 ]
Zhang, Jian [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Heart Failure Ctr, Natl Ctr Cardiovasc Dis,State Key Lab Cardiovasc D, 167 Beilishi Rd, Beijing 10037, Peoples R China
[2] Natl Hlth Comm, Key Lab Clin Res Cardiovasc Medicat, Beijing, Peoples R China
关键词
Heart failure with preserved ejection fraction; Biomarker; Malnutrition-inflammation complex; Machine learning; CELL DISTRIBUTION WIDTH; SERUM URIC-ACID; ALBUMIN; HFPEF; ASSOCIATION; OUTCOMES; HFREF; LIFE;
D O I
10.1186/s12986-024-00856-2
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Metabolic disorder, malnutrition and inflammation are involved and interplayed in the mechanisms of heart failure with preserved ejection fraction (HFpEF). We aimed to construct a Metabolism-malnutrition-inflammation score (MIS) to predict the risk of death in patients with HFpEF. Methods We included patients diagnosed with HFpEF and without infective or systemic disease. 20 biomarkers were filtered by the Least absolute shrinkage and selection operator (Lasso)-Cox regression. 1000 times bootstrapping datasets were generated to select biomarkers that appeared above 95% frequency in repetitions to construct the MIS. Results Among 1083 patients diagnosed with HFpEF, 342 patients (31.6%) died during a median follow-up period of 2.5 years. The MIS was finally constructed based on 6 biomarkers, they were albumin (ALB), red blood cell distribution width-standard deviation (RDW-SD), high-sensitivity C-reactive protein (hs-CRP), lymphocytes, triiodothyronine (T3) and uric acid (UA). Incorporating MIS into the basic predictive model significantly increased both discrimination (triangle C-index = 0.034, 95% CI 0.013-0.050) and reclassification (IDI, 6.6%, 95% CI 4.0%-9.5%; NRI, 22.2% 95% CI 14.4%-30.2%) in predicting all-cause mortality. In the time-dependent receiver operating characteristic (ROC) analysis, the mean area under the curve (AUC) for the MIS was 0.778, 0.782 and 0.772 at 1, 3, and 5 years after discharge in the cross-validation sets. The MIS was independently associated with all-cause mortality (hazard ratio: 1.98, 95% CI [1.70-2.31], P < 0.001). Conclusions A risk score derived from 6 commonly used inflammatory, nutritional, thyroid and uric acid metabolic biomarkers can effectively identify high-risk patients with HFpEF, providing potential individualized management strategies for patients with HFpEF.
引用
收藏
页数:11
相关论文
共 32 条
  • [1] Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure
    Allen, Larry A.
    Felker, G. Michael
    Mehra, Mandeep R.
    Chiong, Jun R.
    Dunlap, Stephanie H.
    Ghali, Jalal K.
    Lenihan, Daniel J.
    Oren, Ron M.
    Wagoner, Lynne E.
    Schwartz, Todd A.
    Adams, Kirkwood F., Jr.
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (03) : 230 - 238
  • [2] Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
    Ambrosio, Giuseppe
    Leiro, Marisa G. Crespo
    Lund, Lars H.
    Coiro, Stefano
    Cardona, Andrea
    Filippatos, Gerasimos
    Ferrari, Roberto
    Piepoli, Massimo F.
    Coats, Andrew J. S.
    Anker, Stefan D.
    Laroche, Cecile
    Almenar-Bonet, Luis
    Poder, Pentti
    Valero, David Bierge
    Frisinghelli, Anna
    Maggioni, Aldo P.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 65 - 75
  • [3] Heidenreich Paul A, 2022, Circulation, V145, pe895, DOI [10.1161/CIR.0000000000001073, 10.1161/CIR.0000000000001063]
  • [4] Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction The VITALITY-HFpEF Randomized Clinical Trial
    Armstrong, Paul W.
    Lam, Carolyn S. P.
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Solomon, Scott D.
    Voors, Adriaan A.
    She, Lilin
    Vlajnic, Vanja
    Carvalho, Francine
    Bamber, Luke
    Blaustein, Robert O.
    Roessig, Lothar
    Butler, Javed
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (15): : 1512 - 1521
  • [5] Human Serum Albumin in the Clinical Syndrome of Heart Failure
    Arques, Stephane
    Ambrosi, Pierre
    [J]. JOURNAL OF CARDIAC FAILURE, 2011, 17 (06) : 451 - 458
  • [6] Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
    Bozkurt, Biykem
    Coats, Andrew J. S.
    Tsutsui, Hiroyuki
    Abdelhamid, Ca Magdy
    Adamopoulos, Stamatis
    Albert, Nancy
    Anker, Stefan D.
    Atherton, John
    Boehm, Michael
    Butler, Javed
    Drazner, Mark H.
    Felker, G. Michael
    Filippatos, Gerasimos
    Fiuzat, Mona
    Fonarow, Gregg C.
    Gomez-Mesa, Juan-Esteban
    Heidenreich, Paul
    Imamura, Teruhiko
    Jankowska, Ewa A.
    Januzzi, James
    Khazanie, Prateeti
    Kinugawa, Koichiro
    Lam, Carolyn S. P.
    Matsue, Yuya
    Metra, Marco
    Ohtani, Tomohito
    Piepoli, Massimo Francesco
    Ponikowski, Piotr
    Rosano, Giuseppe M. C.
    Sakata, Yasushi
    Starling, Randall C.
    Teerlink, John R.
    Vardeny, Orly
    Yamamoto, Kazuhiro
    Yancy, Clyde
    Zhang, Jian
    Zieroth, Shelley
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (03) : 352 - 380
  • [7] Heart failure with preserved ejection fraction: everything the clinician needs to know
    Campbell, Patricia
    Rutten, Frans H.
    Lee, Matthew M. Y.
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    [J]. LANCET, 2024, 403 (10431) : 1083 - 1092
  • [8] Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life
    Cohen, Aaron J.
    Teramoto, Kanako
    Claggett, Brian
    Buckley, Leo
    Solomon, Scott
    Ballantyne, Christie
    Selvin, Elizabeth
    Shah, Amil M.
    [J]. JOURNAL OF CARDIAC FAILURE, 2021, 27 (12) : 1382 - 1392
  • [9] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [10] Incorporating inflammatory biomarkers into a prognostic risk score in patients with non-ischemic heart failure: a machine learning approach
    Feng, Jiayu
    Zhao, Xuemei
    Huang, Boping
    Huang, Liyan
    Wu, Yihang
    Wang, Jing
    Guan, Jingyuan
    Li, Xinqing
    Zhang, Yuhui
    Zhang, Jian
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14